TP53 and cancer: Notably, we found that CD147 knockdown sensitized cancer cells to paclitaxel and Z-VAD-FMK could relieve paclitaxel-induced apoptosis in A549 cells treated with p53 inhibitor Pifithrin-α as well as SK-OV-3 cells overexpressing p53 (Supplementary Fig. 4).